Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma.
Br J Haematol. 2024 Feb;204(2):555-560. doi: 10.1111/bjh.19183. Epub 2023 Nov 14.
Br J Haematol. 2024.
PMID: 37963444
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice.
Ascrizzi S, Arillotta GM, Grillone K, Caridà G, Signorelli S, Ali A, Romeo C, Tassone P, Tagliaferri P.
Ascrizzi S, et al.
Cancers (Basel). 2023 Aug 2;15(15):3930. doi: 10.3390/cancers15153930.
Cancers (Basel). 2023.
PMID: 37568746
Free PMC article.
Review.
Item in Clipboard
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer.
Riillo C, Polerà N, Di Martino MT, Juli G, Hokanson CA, Odineca T, Signorelli S, Grillone K, Ascrizzi S, Mancuso A, Staropoli N, Caparello B, Cerra M, Nisticò G, Tagliaferri P, Crea R, Caracciolo D, Tassone P.
Riillo C, et al. Among authors: ascrizzi s.
J Transl Med. 2023 May 4;21(1):301. doi: 10.1186/s12967-023-04101-x.
J Transl Med. 2023.
PMID: 37143061
Free PMC article.
Item in Clipboard
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.
Polerà N, Mancuso A, Riillo C, Caracciolo D, Signorelli S, Grillone K, Ascrizzi S, Hokanson CA, Conforti F, Staropoli N, Gervasi L, Di Martino MT, Arbitrio M, Nisticò G, Crea R, Tagliaferri P, Juli G, Tassone P.
Polerà N, et al. Among authors: ascrizzi s.
Cancers (Basel). 2023 Mar 8;15(6):1647. doi: 10.3390/cancers15061647.
Cancers (Basel). 2023.
PMID: 36980534
Free PMC article.
Item in Clipboard
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma.
Scionti F, Juli G, Rocca R, Polerà N, Nadai M, Grillone K, Caracciolo D, Riillo C, Altomare E, Ascrizzi S, Caparello B, Cerra M, Arbitrio M, Richter SN, Artese A, Alcaro S, Tagliaferri P, Tassone P, Di Martino MT.
Scionti F, et al. Among authors: ascrizzi s.
J Exp Clin Cancer Res. 2023 Mar 27;42(1):71. doi: 10.1186/s13046-023-02633-0.
J Exp Clin Cancer Res. 2023.
PMID: 36967378
Free PMC article.
Item in Clipboard
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
Grillone K, Riillo C, Rocca R, Ascrizzi S, Spanò V, Scionti F, Polerà N, Maruca A, Barreca M, Juli G, Arbitrio M, Di Martino MT, Caracciolo D, Tagliaferri P, Alcaro S, Montalbano A, Barraja P, Tassone P.
Grillone K, et al. Among authors: ascrizzi s.
Int J Mol Sci. 2022 Sep 6;23(18):10222. doi: 10.3390/ijms231810222.
Int J Mol Sci. 2022.
PMID: 36142133
Free PMC article.
Item in Clipboard
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells.
Riillo C, Caracciolo D, Grillone K, Polerà N, Tuccillo FM, Bonelli P, Juli G, Ascrizzi S, Scionti F, Arbitrio M, Lopreiato M, Siciliano MA, Sestito S, Talarico G, Galea E, Galati MC, Pensabene L, Loprete G, Rossi M, Ballerini A, Gentile M, Britti D, Di Martino MT, Tagliaferri P, Tassone P.
Riillo C, et al. Among authors: ascrizzi s.
Cancers (Basel). 2022 Jun 11;14(12):2886. doi: 10.3390/cancers14122886.
Cancers (Basel). 2022.
PMID: 35740552
Free PMC article.
Item in Clipboard
Cite
Cite